lansoprazole has been researched along with Malignant Melanoma in 3 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of Lansoprazole (LAN) and CA IX inhibitors (FC9-399A and S4) has been investigated in terms of cell proliferation inhibition and cell death in human melanoma cells." | 7.83 | Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells. ( Azzarito, T; Carta, F; Fais, S; Federici, C; Iessi, E; Lugini, L; Marino, ML; Supuran, CT, 2016) |
| " The main purpose of the present study was to evaluate the possible PPI-induced sensitization of human melanoma cells to Paclitaxel (PTX)." | 7.81 | Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma. ( Azzarito, T; Cesolini, A; Fais, S; Venturi, G, 2015) |
| "The combination of Lansoprazole (LAN) and CA IX inhibitors (FC9-399A and S4) has been investigated in terms of cell proliferation inhibition and cell death in human melanoma cells." | 3.83 | Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells. ( Azzarito, T; Carta, F; Fais, S; Federici, C; Iessi, E; Lugini, L; Marino, ML; Supuran, CT, 2016) |
| " The main purpose of the present study was to evaluate the possible PPI-induced sensitization of human melanoma cells to Paclitaxel (PTX)." | 3.81 | Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma. ( Azzarito, T; Cesolini, A; Fais, S; Venturi, G, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azzarito, T | 2 |
| Venturi, G | 1 |
| Cesolini, A | 1 |
| Fais, S | 3 |
| Federici, C | 2 |
| Lugini, L | 2 |
| Marino, ML | 1 |
| Carta, F | 1 |
| Iessi, E | 2 |
| Supuran, CT | 1 |
| Sciamanna, I | 1 |
| Spugnini, EP | 1 |
3 other studies available for lansoprazole and Malignant Melanoma
| Article | Year |
|---|---|
Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Drug Resistance, Neoplasm | 2015 |
Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cel | 2016 |
Antitumor effect of combination of the inhibitors of two new oncotargets: proton pumps and reverse transcriptase.
Topics: Alkynes; Antineoplastic Combined Chemotherapy Protocols; Benzoxazines; Cell Line, Tumor; Cell Prolif | 2017 |